Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib at 2mg and 4mg doses improved work productivity and reduced costs for adults with atopic dermatitis.

All four treatments for early rheumatoid arthritis had similar and mostly mild side effects.

Testosterone with finasteride improved muscle and bone health in men with spinal cord injury.

Off-label treatments are heavily used for alopecia areata due to limited approved options.

Dental procedures and treatments show promise but need more research for conclusive results.

Androgenetic alopecia treatments slightly increase the risk of side effects, especially sexual dysfunction and skin reactions.

Clascoterone is safe for the heart, even at high doses.

Deuruxolitinib improves hair regrowth in alopecia areata but needs more safety research.

Baricitinib and tofacitinib have different safety patterns in treating alopecia areata.

Long-term testosterone treatment helps men with low testosterone levels lose weight.

SRD5A2 methylation in blood can predict how well someone will respond to finasteride treatment.

Human stem cells can aid stroke recovery, research experiences boost students' career aspirations, minoxidil may reduce cancer spread, a molecule can slow tumor growth, a protein affects water flow in cells, magnesium behaves differently at tiny scales, and a new method detects slow-moving objects.

Fractional CO2 laser with topical triamcinolone is more effective and safer for treating alopecia areata than intralesional triamcinolone.

Low-Level Laser Therapy may help reduce chronic pelvic pain in women.

Low-intensity shock wave therapy is effective in treating erectile dysfunction in diabetic patients.

The dietary supplement AGA-P improves the effectiveness of hair loss treatments.

Alopecia Areata significantly lowers quality of life and current treatments are inadequate, highlighting a need for better therapies and standardized treatment protocols.

MK-0773 safely increased muscle mass but did not improve muscle strength or function in elderly women with sarcopenia.

Photobiomodulation may improve certain health conditions, but more high-quality research is needed.

5-Alpha reductase inhibitors may prevent prostate cancer but are not widely used due to concerns about trial relevance and potential risks, and more research is needed to confirm long-term benefits.

Intralesional corticosteroids are best for mild alopecia areata, and DPCP is best for severe cases.

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

PRP treatment lacks strong evidence for routine use due to poor study quality.

The study aims to find the best PRP dose for treating moderate carpal tunnel syndrome.

PRP is a promising and safe treatment for early to moderate knee osteoarthritis but needs standardized protocols.

Baricitinib was effective and safe for severe hair loss treatment over 6 months.

Future hormone therapy trials should match the diverse needs and priorities of the gender-diverse community.

Experts agreed on guidelines to improve research on Frontal Fibrosing Alopecia.

SHPro® improved urinary symptoms and erectile function in men and is safe.

"Flosin – Prostamol Uno" effectively manages BPH symptoms with fewer side effects.